CoChat

Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial

Open access
Sano, Mary, Aisen, Paul S., Andrews, Howard F., Tsai, Wei-Yann, Lai, Florence, Dalton, Arthur J., For the International Down Syndrome and Alzheimer's Disease Consortium, International Down Syndrome and Alzheimer's Disease Consortium, McCallion, Philip, Zendell, Anna, Mintz, Mark, Young, Jean M, Parmenter, Trevor R, Durvasua, Seeta, Riches, Vivienne, Yazbeck, Marie, Shellard, Nicky, Friedlander, Robin, Klancnik, Joseph, Watt, Kim, Gratigny, Steffi, Tsiouris, John, Patti, Paul, Prasher, Vee, Singh, Baldiv, Murphy, Declan, Lai, Florence, Beauchesne, Michelle, Lawlor, Brian, McCarron, Mary, Rubin, Leslie, Pomaro, Nunzio, Hernando, Raymundo T., Crowell, Timothy A, Thorpe, Lillian, Percy, Maire E., Pasternak, Stephen H., Lovering, Ann M., Stone, James, Kerins, Gerard, Gruman, Cynthia, Heller, Tamar, Hsieh, Kelly, Macmillan, Carol, Batty, Karen N, Capone, George, Lerner, Alan J., Hudson, Leon · 2016 · Neurology
Cited by 61

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To determine whether vitamin E would slow the progression of cognitive deterioration and dementia in aging persons with Down syndrome (DS). METHODS: A randomized, double-blind controlled clinical trial was conducted at 21 clinical sites, and researchers trained in research procedures recruited adults with DS older than 50 years to participate. Participants were randomly assigned to receive 1,000 IU of vitamin E orally twice daily for 3 years or identical placebo. The primary outcome was change on the Brief Praxis Test (BPT). Secondary outcomes included incident dementia and measures of clinical global change, cognition, function, and behavior. RESULTS: A total of 337 individuals were randomized, 168 to vitamin E and 169 to placebo. Both groups demonstrated deterioration on the BPT with no difference between drug and placebo. At baseline, 26% were diagnosed with dementia and there was an overall rate of incident dementia of 11%/year with no difference between groups. There was no effect on the secondary outcome measures. Though numerically higher in the treatment group, there was no difference in the number of adverse events (p = 0.079) and deaths (p = 0.086) between groups. CONCLUSIONS: Vitamin E did not slow the progression of cognitive deterioration in older individuals with DS. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that vitamin E does not significantly slow the progression of cognitive deterioration in aging persons with DS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000002714

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 61

Metadata

Authors
Sano, M., Aisen, P. S., Andrews, H. F., Tsai, W.-Y., Lai, F., Dalton, A. J., For the International Down Syndrome and Alzheimer's Disease Consortium, International Down Syndrome and Alzheimer's Disease Consortium, McCallion, P., Zendell, A., Mintz, M., Young, J. M., Parmenter, T. R., Durvasua, S., Riches, V., Yazbeck, M., Shellard, N., Friedlander, R., Klancnik, J., Watt, K., Gratigny, S., Tsiouris, J., Patti, P., Prasher, V., Singh, B., Murphy, D., Lai, F., Beauchesne, M., Lawlor, B., McCarron, M., Rubin, L., Pomaro, N., Hernando, R. T., Crowell, T. A., Thorpe, L., Percy, M. E., Pasternak, S. H., Lovering, A. M., Stone, J., Kerins, G., Gruman, C., Heller, T., Hsieh, K., Macmillan, C., Batty, K. N., Capone, G., Lerner, A. J., & Hudson, L.
Venue
Neurology
Published
2016-05-31
Volume
86
Issue
22
Pages
2071-2076
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2347148793
Cited by
61
References
10
FWCI
6.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial. https://app.cochat.ai/papers/10.1212/wnl.0000000000002714
The paper
Sano, M., Aisen, P. S., Andrews, H. F., Tsai, W.-Y., Lai, F., Dalton, A. J., For the International Down Syndrome and Alzheimer's Disease Consortium, International Down Syndrome and Alzheimer's Disease Consortium, McCallion, P., Zendell, A., Mintz, M., Young, J. M., Parmenter, T. R., Durvasua, S., Riches, V., Yazbeck, M., Shellard, N., Friedlander, R., Klancnik, J., . . . Hudson, L. (2016). Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial. Neurology. https://doi.org/10.1212/wnl.0000000000002714

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.